A Multicentric, Retrospective, Real-world Study on Immune-related Adverse Events in Patients with Advanced Non-small Cell Lung Cancers Treated with Pembrolizumab Monotherapy by Lerner, A., Lee, A.J.X., Yan, H., Van Griethuysen, J., Bartlett, A.D., Veli, M., Jiang, Y., Luong, M., Naban, N., Kane, C., Conibear, J., Papadatos-Pastos, D., Ahmad, T., Chao, D., Anand, G., Asghar, U.S.

Get full text